Fresenius Medical Care Value Stock - Dividend - Research Selection

Fresenius Medical Care AG & Co. KGaA (ISIN: DE0005785802 , WKN: 578580) Market price date: 17.08.2018 Market price: 85,02 EUR
Description Data
Symbol FME.DE
Market Capitalization 29.758.742.528,00 USD
Country Deutschland
Indices DaxHDAX
Sector Gesundheitswesen
Raw Data Source IFRS in Millionen EUR
Stock Split 2007-06-18 - 3.0000/1.0000 |
Internet www.freseniusmedicalcare.com
Last Balance Sheet Update 06.04.2018

Fundamentals

Fundamental ratios calculated on: 17-08-2018
P/FC P/C Div. Yield ROI ROE P/E P/S P/B
19,30 11,92 1,25% 5,33 40,87 20,44 1,47 2,66

Description of the company

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient\'s residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist and intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers non-dialysis products, including acute cardiopulmonary and apheresis products. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2017, it operated 3,752 outpatient dialysis clinics in approximately 50 countries. The company has operations in Germany, the United States, and internationally. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.freseniusmedicalcare.com